×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Faculty of Healt... [4]
Institute of Chi... [1]
THE STATE KEY LA... [1]
Authors
XU REN HE [3]
LEI CHON LOK [2]
OUYANG DEFANG [1]
JUNG WOO PARK [1]
Document Type
Journal article [3]
Other [1]
Review article [1]
Date Issued
2024 [1]
2023 [2]
2021 [2]
Language
英語English [4]
Source Publication
Frontiers in Imm... [2]
Acta Pharmaceuti... [1]
International Jo... [1]
Science Bulletin [1]
Indexed By
SCIE [4]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-5 of 5
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Corrigendum: Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao (Frontiers in Immunology, (2023), 14, (1131985), 10.3389/fimmu.2023.1131985)
Other
2024-01-01
Authors:
Ng, Hoi Man
;
Lei, Chon Lok
;
Fu, Siyi
;
Li, Enqin
;
Leong, Sek In
; et al.
Favorite
|
TC[WOS]:
0
TC[Scopus]:
0
|
Submit date:2024/05/16
Antibodies
Heterologous Vaccinations
Inactivated Vaccine
Macao
Mrna Vaccine
Nucleocapsid Proteins
Sars-cov-2
Spike Proteins
Classification of five SARS-CoV-2 serotypes based on RBD antigenicities
Journal article
Hu, Shixiong, Wu, Chunli, Wu, Xinkai, Ma, Xuehui, Shu, Chang, Chen, Qian, Zheng, Anqi, Yang, Huiting, Lu, Jian, Du, Pei, Gao, George Fu, Wang, Qihui. Classification of five SARS-CoV-2 serotypes based on RBD antigenicities[J]. Science Bulletin, 2023, 68(23), 3003-3012.
Authors:
Hu, Shixiong
;
Wu, Chunli
;
Wu, Xinkai
;
Ma, Xuehui
;
Shu, Chang
; et al.
Favorite
|
TC[WOS]:
9
TC[Scopus]:
12
IF:
18.8
/
15.8
|
Submit date:2024/02/22
Mrna Vaccine
Receptor-binding Domain (Rbd)
Sars-cov-2
Serotype Classification
Spike (s)
Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao
Journal article
Ng,Hoi Man, Lei,Chon Lok, Fu,Siyi, Li,Enqin, Leong,Sek In, Nip,Chu Iong, Choi,Nga Man, Lai,Kai Seng, Tang,Xi Jun, Lei,Chon Leng, Xu,Ren He. Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao[J]. Frontiers in Immunology, 2023, 14.
Authors:
Ng,Hoi Man
;
Lei,Chon Lok
;
Fu,Siyi
;
Li,Enqin
;
Leong,Sek In
; et al.
Favorite
|
TC[WOS]:
3
TC[Scopus]:
2
IF:
5.7
/
6.8
|
Submit date:2023/08/03
Antibodies
Heterologous Vaccinations
Inactivated Vaccine
Macao
Mrna Vaccine
Nucleocapsid Proteins
Sars-cov-2
Spike Proteins
Prediction of lipid nanoparticles for mRNA vaccines by the machine learning algorithm
Journal article
Wang, Wei, Feng, Shuo, Ye, Zhuyifan, Gao, Hanlu, Lin, Jinzhong, Ouyang, Defang. Prediction of lipid nanoparticles for mRNA vaccines by the machine learning algorithm[J]. Acta Pharmaceutica Sinica B, 2021, 12(6), 2950 - 2962.
Authors:
Wang, Wei
;
Feng, Shuo
;
Ye, Zhuyifan
;
Gao, Hanlu
;
Lin, Jinzhong
; et al.
Favorite
|
TC[WOS]:
55
TC[Scopus]:
58
IF:
14.7
/
14.1
|
Submit date:2022/05/17
Formulation Prediction
Ionizable Lipid
Lightgbm
Lipid Nanoparticle
Machine Learning
Molecular Modeling
Mrna
Vaccine
Mrna vaccines for covid-19: What, why and how
Review article
2021
Authors:
Park, Jung Woo
;
Lagniton, Philip N.P.
;
Liu, Yu
;
Xu, Ren He
Adobe PDF
|
Favorite
|
TC[WOS]:
185
TC[Scopus]:
210
IF:
8.2
/
8.3
|
Submit date:2021/11/30
Covid-19
Efficacy And Safety
Mrna Vaccine
Sars-cov-2